Efflux pump and biofilm study in pseudomonas infections
Part of Infections clinical trials.
This study looks at bacteria called Pseudomonas aeruginosa that cause infections. It checks how these bacteria resist antibiotics by studying their genes and ability to form biofilms, which might help find better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have an infection caused by Pseudomonas aeruginosa bacteria.
- The bacteria sample can come from a wound, sputum, urine, blood, or catheter.
- Only one sample per patient is needed.
- The sample must be confirmed as Pseudomonas aeruginosa by a lab test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the bacteria in the gut of people who are very ill in the hospital. It may help doctors understand how gut health affects recovery.
This study looks at how Klebsiella pneumoniae bacteria that are resistant to many antibiotics form a protective layer (biofilm) and pump out drugs (efflux pump activity). By understanding these mechanisms, doctors may find better ways to treat these tough infections.
This study tests a specific antibiotic plan for adults with a hard-to-treat Pseudomonas infection that needs IV medicine. It aims to find the best way to treat these serious infections.
This study looks at new ways to fight antibiotic-resistant bacteria in people with certain common infections. It may help by testing approaches tailored to the specific germs found in your urine, lungs, or deeper infections.
This study looks at people’s blood to see if they already have antibodies that recognize Pseudomonas aeruginosa, a type of bacteria. If you qualify for the prospective part, they may collect blood samples at Grenoble University Hospital and use your results to support future treatment testing.
This study tests different antibiotic combinations for severe infections caused by hard-to-treat Gram-negative bacteria (like Pseudomonas or Acinetobacter). The goal is to find the best treatment for bloodstream infections or pneumonia that started in the hospital.
Hear when a new Pseudomonas Aeroginosa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.